SCHEMBL3366873

SCHEMBL3366873

CNc1cccc2c1CCCC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
LMNA P02545 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
THRA P10827 1/20 0.53
THRB P10828 1/20 0.53
HTT P42858 2/20 0.50
BCL2L1 Q07817 1/20 0.50
BAD Q92934 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
KDM4E B2RXH2 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866604 0.98 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL8312391 0.96 NISCH (0.51) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL7905159 0.83 BCL2L1 (0.54) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL12101466 0.83 MEN1 (0.56) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL18906788 0.80 ALDH1A1 (0.51) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL19112709 0.80 NISCH (0.49) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL7262779 0.79 SIGMAR1 (0.53) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL12883500 0.79 ALDH1A1 (0.50) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL8166642 0.79 HTT (0.58) ALDH1A1LMNAMEN1KMT2ATHRA
SCHEMBL7961751 0.78 SIGMAR1 (0.51) ALDH1A1LMNAMEN1KMT2ATHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303586-A1 INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2023-09-28 US disclosed
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed
WO-2023125627-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND APPLICATION THEREOF LYNK PHARMACEUTICALS CO., LTD. (CN) 2023-07-06 WO disclosed
WO-2022036297-A1 NON-HYDRATED KETONE INHIBITORS OF NAV1.7 FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS, INC. (US) 2022-02-17 WO disclosed
EP-3822270-A1 NOVEL HETEROCYCLE DERIVATIVE JW Pharmaceutical Corporation (KR) 2021-05-19 EP disclosed
US-10254645-B2 Photosensitive resin composition, method for producing cured film, cured film, liquid crystal display device, organic electroluminescent display device, and touch panel FUJIFILM CORPORATION (JP) 2019-04-09 US disclosed
US-20170168391-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED FILM, CURED FILM, LIQUID CRYSTAL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND TOUCH PANEL FUJIFILM CORPORATION (JP) 2017-06-15 US disclosed
US-20170168391-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED FILM, CURED FILM, LIQUID CRYSTAL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND TOUCH PANEL FUJIFILM CORPORATION (JP) 2017-06-15 US disclosed
US-20170152229-A1 TETRAHYDROISOQUINOLINONE DERIVATIVES AND THEIR USE IN THE INHIBITION OF THE HSP70 PROTEIN JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (DE) 2017-06-01 US disclosed
US-20140031368-A1 SELECTIVE HDAC INHIBITORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-01-30 US disclosed
US-20070049570-A1 Quinoline derivatives as phosphodiesterase inhibitors DEAN ANTHONY W 2007-03-01 US disclosed
US-6878510-B2 Method of processing silver halide photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 2005-04-12 US disclosed
US-20050032008-A1 Silver halide color photosensitive material FUJI PHOTO FILM CO., LTD. 2005-02-10 US disclosed
US-6844146-B2 Silver halide color photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 2005-01-18 US disclosed
WO-2004103998-A1 QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-12-02 WO disclosed
US-20040058282-A1 Method of processing silver halide photosensitive material FUJI PHOTO FILM CO., LTD. 2004-03-25 US disclosed
US-6696215-B2 HIGH CONTRAST AND PHOTOSENSITIVITY FUJI PHOTO FILM CO., LTD. (JP) 2004-02-24 US disclosed
US-20040018458-A1 Photothermographic material FUJIFILM CORPORATION (JP) 2004-01-29 US disclosed
US-20030232272-A1 Silver halide photographic light sensitive material FUJIFILM CORPORATION (JP) 2003-12-18 US disclosed
US-20030198905-A1 Silver halide color photosensitive material FUJI PHOTO FILM CO., LTD. 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152229-A1 TETRAHYDROISOQUINOLINONE DERIVATIVES AND THEIR USE IN THE INHIBITION OF THE HSP70 PROTEIN HSPH1, HSP90AB1, HSP90AB2P ALDH1A1 2256/4885LMNA 4452/4885MEN1 4303/4885
US-20140031368-A1 SELECTIVE HDAC INHIBITORS HDAC1, HDAC11, HDAC3 ALDH1A1 1489/4885LMNA 1269/4885MEN1 2678/4885
US-20070049570-A1 Quinoline derivatives as phosphodiesterase inhibitors PDE3B, PDE4B, PDE4A ALDH1A1 623/4885LMNA 2744/4885MEN1 2927/4885
US-20230303586-A1 INHIBITORS OF KRAS G12C KRAS, NRAS, HRAS ALDH1A1 4178/4885LMNA 407/4885MEN1 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.